Clinical Scorecard: Dual-layer spectral computed tomography for mapping iodine and assessing surrogate perfusion in cerebrovascular conditions

At a Glance

Key Highlights

• DLCT enables iodine density mapping and virtual monochromatic imaging as static surrogates for cerebral perfusion with reduced radiation exposure.
• Strong correlation found between DLCT spectral CT perfusion parameters and conventional dynamic CTP, especially at 60 keV VMIs.
• DLCT iodine maps may be useful when CTP is contraindicated or impractical but do not replace dynamic perfusion parameters like CBF or MTT.

Guideline-Based Recommendations

Diagnosis

• Use DLCT-derived iodine density maps as supportive imaging for cerebral perfusion assessment in cerebrovascular diseases.
• Employ virtual monochromatic images at 60 keV for improved correlation with conventional CTP perfusion parameters.

Management

• Consider DLCT to reduce radiation dose by up to 39% compared to conventional CTP, especially in patients requiring repeated imaging.
• Use DLCT iodine maps to complement or potentially reduce the need for dynamic CTP in selected clinical scenarios.

Monitoring & Follow-up

• Utilize DLCT iodine mapping for serial assessments in chronic cerebrovascular monitoring to minimize cumulative radiation exposure.

Risks

• Recognize that DLCT iodine maps do not provide time-resolved perfusion parameters essential for acute stroke triage.
• Be cautious interpreting DLCT iodine maps as surrogates for cerebral blood flow without prospective validation.

Patient & Prescribing Data

Patients with cerebrovascular disorders undergoing cerebral perfusion imaging

DLCT offers a lower radiation alternative to conventional CTP with reliable estimation of perfusion metrics, suitable for repeated imaging and patients contraindicated for dynamic CTP.

Clinical Best Practices

• Incorporate DLCT iodine density maps and VMIs as adjuncts to conventional perfusion imaging to enhance tissue differentiation and reduce radiation dose.
• Prefer 60 keV virtual monochromatic images for optimal correlation with dynamic perfusion parameters.
• Use DLCT iodine mapping cautiously as a static surrogate and not a replacement for dynamic perfusion parameters in acute stroke management.
• Streamline imaging protocols by combining vascular and perfusion assessment in a single DLCT angiography scan when appropriate.
• Await prospective multicenter validation before fully substituting DLCT iodine maps for conventional CTP in clinical decision-making.

References

• Liu et al study on DLCT and cerebral perfusion
• Background on cerebral perfusion CT parameters
• Radiation dose concerns in cerebral perfusion CT
• Spectral CT iodine mapping and virtual monochromatic imaging
• DLCT iodine quantification in pancreatic and myocardial perfusion